CRITICARE SYSTEMS, INC. (AMEX:CMD). Criticare Systems, Inc. today
announced financial results for the fiscal 2006 year ended June 30,
2006 and the quarterly conference call details For the fiscal year
ended June 30, 2006, the company had net sales of $31,350,919 and
net income of $212,118 as compared to net sales of $26,781,627 and
a net loss of $(422,245) in fiscal 2005. The revenue is the second
largest in the company�s history and the net income is the first
annual profit for the company in 11 years. Criticare�s businesses
reflecting gains were Acute Care, OEM and International sales.
Monitor placements in our Oral Surgery business also increased
slightly but overall revenue declined primarily due to the company
exiting the defibrillator market. Fourth quarter net sales for
fiscal 2006 of $7,095,962 were 11.5% lower than the $8,020,894 in
net sales for the same period of fiscal 2005, principally due to
the strong introductory requirement for MR monitors in fiscal 2005.
The company had a net loss of $(524,220) for the fourth quarter of
fiscal 2006 that included a charge of $529,700 to reserve a portion
of an international receivable. This compares to net income of
$371,271 for the fourth quarter of fiscal 2005. Criticare will hold
a quarterly conference call on Monday, October 2, 2006 at 10:00 am
central daylight time to discuss the year end results of fiscal
2006. The call can be accessed by dialing 1-877-407-0782. CSI
(www.csiusa.com) designs, manufactures, and markets cost-effective
patient monitoring systems and noninvasive sensors for a wide range
of hospitals and alternate health care environments throughout the
world. This press release contains forward-looking statements. Such
statements refer to the Company's beliefs and expectations.
Forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those described. Such uncertainties include, but are not
limited to, the timely completion of new products, regulatory
approvals for new products, the risk of new and better
technologies, risks relating to international markets, as well as
general conditions and competition in the company's markets. Other
risks are set forth in CSI�s reports and documents filed from time
to time with the Securities and Exchange Commission. CRITICARE
SYSTEMS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF
OPERATIONS YEARS ENDED JUNE 30, 2006, 2005 AND 2004 � � 2006 2005
2004 � NET SALES $31,350,919� $26,781,627� $28,591,481� � COST OF
GOODS SOLD 19,308,353� 16,311,144� 16,821,782� � GROSS PROFIT
12,042,566� 10,470,483� 11,769,699� � OPERATING EXPENSES: Sales and
marketing 6,950,311� 5,670,505� 7,150,867� Research, development
and engineering 2,362,512� 2,620,134� 2,532,129� Administrative
3,177,232� 2,906,039� 3,661,216� Total 12,490,055� 11,196,678�
13,344,212� � LOSS FROM OPERATIONS (447,489) (726,195) (1,574,513)
� OTHER (EXPENSE) INCOME: Interest expense (19,820) (28,848)
(9,282) Interest income 94,830� 58,710� 37,176� Foreign currency
exchange gain (loss) (108,225) 131,885� --� Other income (expense)
692,822� 142,203� (553,954) Total 659,607� 303,950� (526,060) �
INCOME (LOSS) BEFORE INCOME TAXES 212,118� (422,245) (2,100,573) �
INCOME TAX PROVISION --� --� --� � NET INCOME (LOSS) $ 212,118� $
(422,245) $ (2,100,573) � NET INCOME (LOSS) PER COMMON SHARE: Basic
and diluted $0.02� $(0.04) $(0.19) � WEIGHTED AVERAGE NUMBER OF
COMMON SHARES OUTSTANDING: Basic 12,069,060� 11,514,786�
11,240,685� Diluted 12,256,431� 11,514,786� 11,240,685� CRITICARE
SYSTEMS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS JUNE 30,
2006 AND 2005 � � ASSETS 2006 2005 � CURRENT ASSETS: Cash and cash
equivalents $3,793,781� $3,680,965� Accounts receivable, less
allowance for doubtful accounts of $829,700 and $300,000,
respectively 6,187,351� 6,847,432� Other receivables 591,008�
645,479� Short term note receivable 50,000� --� Inventories
9,464,037� 5,551,093� Prepaid expenses 227,606� 255,104� Total
current assets 20,313,783� 16,980,073� � PROPERTY, PLANT AND
EQUIPMENT: Machinery and equipment 3,157,328� 2,800,269� Furniture
and fixtures 952,193� 947,726� Leasehold improvements 243,604�
220,407� Demonstration and loaner monitors 1,997,844� 1,352,267�
Production tooling 2,294,360� 2,009,809� Property, plant and
equipment � cost 8,645,329� 7,330,478� Less accumulated
depreciation 6,193,015� 5,320,061� Property, plant and equipment �
net 2,452,314� 2,010,417� � OTHER ASSETS: License rights and
patents � net 62,981� 69,983� Long term note receivable 150,000�
--� Total other assets 212,981� 69,983� TOTAL ASSETS $22,979,078�
$19,060,473� LIABILITIES AND STOCKHOLDERS' EQUITY 2006 2005 �
CURRENT LIABILITIES: Accounts payable $5,408,746� $3,033,559�
Accrued liabilities: Compensation and commissions 914,889� 900,636�
Product warranties 425,000� 452,000� Obligations under capital
lease 68,205� 62,739� Other 174,667� 191,807� Total current
liabilities 6,991,507� 4,640,741� � LONG-TERM LIABILITIES:
Obligations under capital lease 133,826� 202,031� Other long-term
obligations 659� 8,561� Total long-term liabilities 134,485�
210,592� � COMMITMENTS AND CONTINGENCIES � TOTAL LIABILITIES
7,125,992� 4,851,333� � STOCKHOLDERS' EQUITY: Preferred stock -
$.04 par value, 500,000 shares authorized, no shares issued or
outstanding --� --� Common stock - $.04 par value, 15,000,000
shares authorized, 12,398,131 and 11,925,086 shares issued, and
12,291,454 and 11,812,493 outstanding, respectively 495,925�
477,003� Additional paid-in capital 26,156,864� 24,775,995� Common
stock held in treasury (106,677 and 112,593 shares, respectively)
(375,813) (386,834) � Retained earnings (accumulated deficit)
(10,436,794) (10,648,912) Cumulative translation adjustment 12,904�
(8,112) Total stockholders' equity 15,853,086� 14,209,140� TOTAL
LIABILITIES AND STOCKHOLDERS� EQUITY $22,979,078� $19,060,473�
CRITICARE SYSTEMS, INC. (AMEX:CMD). Criticare Systems, Inc. today
announced financial results for the fiscal 2006 year ended June 30,
2006 and the quarterly conference call details For the fiscal year
ended June 30, 2006, the company had net sales of $31,350,919 and
net income of $212,118 as compared to net sales of $26,781,627 and
a net loss of $(422,245) in fiscal 2005. The revenue is the second
largest in the company's history and the net income is the first
annual profit for the company in 11 years. Criticare's businesses
reflecting gains were Acute Care, OEM and International sales.
Monitor placements in our Oral Surgery business also increased
slightly but overall revenue declined primarily due to the company
exiting the defibrillator market. Fourth quarter net sales for
fiscal 2006 of $7,095,962 were 11.5% lower than the $8,020,894 in
net sales for the same period of fiscal 2005, principally due to
the strong introductory requirement for MR monitors in fiscal 2005.
The company had a net loss of $(524,220) for the fourth quarter of
fiscal 2006 that included a charge of $529,700 to reserve a portion
of an international receivable. This compares to net income of
$371,271 for the fourth quarter of fiscal 2005. Criticare will hold
a quarterly conference call on Monday, October 2, 2006 at 10:00 am
central daylight time to discuss the year end results of fiscal
2006. The call can be accessed by dialing 1-877-407-0782. CSI
(www.csiusa.com) designs, manufactures, and markets cost-effective
patient monitoring systems and noninvasive sensors for a wide range
of hospitals and alternate health care environments throughout the
world. This press release contains forward-looking statements. Such
statements refer to the Company's beliefs and expectations.
Forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those described. Such uncertainties include, but are not
limited to, the timely completion of new products, regulatory
approvals for new products, the risk of new and better
technologies, risks relating to international markets, as well as
general conditions and competition in the company's markets. Other
risks are set forth in CSI's reports and documents filed from time
to time with the Securities and Exchange Commission. -0- *T
CRITICARE SYSTEMS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF
OPERATIONS YEARS ENDED JUNE 30, 2006, 2005 AND 2004 2006 2005 2004
------------ ------------ ------------ NET SALES $31,350,919
$26,781,627 $28,591,481 COST OF GOODS SOLD 19,308,353 16,311,144
16,821,782 ------------ ------------ ------------ GROSS PROFIT
12,042,566 10,470,483 11,769,699 OPERATING EXPENSES: Sales and
marketing 6,950,311 5,670,505 7,150,867 Research, development and
engineering 2,362,512 2,620,134 2,532,129 Administrative 3,177,232
2,906,039 3,661,216 ------------ ------------ ------------ Total
12,490,055 11,196,678 13,344,212 LOSS FROM OPERATIONS (447,489)
(726,195) (1,574,513) OTHER (EXPENSE) INCOME: Interest expense
(19,820) (28,848) (9,282) Interest income 94,830 58,710 37,176
Foreign currency exchange gain (loss) (108,225) 131,885 -- Other
income (expense) 692,822 142,203 (553,954) ------------
------------ ------------ Total 659,607 303,950 (526,060) INCOME
(LOSS) BEFORE INCOME TAXES 212,118 (422,245) (2,100,573) INCOME TAX
PROVISION -- -- -- ------------ ------------ ------------ NET
INCOME (LOSS) $212,118 $(422,245) $(2,100,573) ============
============ ============ NET INCOME (LOSS) PER COMMON SHARE: Basic
and diluted $0.02 $(0.04) $(0.19) WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING: Basic 12,069,060 11,514,786 11,240,685 Diluted
12,256,431 11,514,786 11,240,685 *T -0- *T CRITICARE SYSTEMS, INC.
AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS JUNE 30, 2006 AND 2005
ASSETS 2006 2005 ------------ ------------ CURRENT ASSETS: Cash and
cash equivalents $3,793,781 $3,680,965 Accounts receivable, less
allowance for doubtful accounts of $829,700 and $300,000,
respectively 6,187,351 6,847,432 Other receivables 591,008 645,479
Short term note receivable 50,000 -- Inventories 9,464,037
5,551,093 Prepaid expenses 227,606 255,104 ------------
------------ Total current assets 20,313,783 16,980,073 PROPERTY,
PLANT AND EQUIPMENT: Machinery and equipment 3,157,328 2,800,269
Furniture and fixtures 952,193 947,726 Leasehold improvements
243,604 220,407 Demonstration and loaner monitors 1,997,844
1,352,267 Production tooling 2,294,360 2,009,809 ------------
------------ Property, plant and equipment - cost 8,645,329
7,330,478 Less accumulated depreciation 6,193,015 5,320,061
------------ ------------ Property, plant and equipment - net
2,452,314 2,010,417 OTHER ASSETS: License rights and patents - net
62,981 69,983 Long term note receivable 150,000 -- ------------
------------ Total other assets 212,981 69,983 ------------
------------ TOTAL ASSETS $22,979,078 $19,060,473 ============
============ *T -0- *T LIABILITIES AND STOCKHOLDERS' EQUITY 2006
2005 ------------ ------------ CURRENT LIABILITIES: Accounts
payable $5,408,746 $3,033,559 Accrued liabilities: Compensation and
commissions 914,889 900,636 Product warranties 425,000 452,000
Obligations under capital lease 68,205 62,739 Other 174,667 191,807
------------ ------------ Total current liabilities 6,991,507
4,640,741 LONG-TERM LIABILITIES: Obligations under capital lease
133,826 202,031 Other long-term obligations 659 8,561 ------------
------------ Total long-term liabilities 134,485 210,592
COMMITMENTS AND CONTINGENCIES TOTAL LIABILITIES 7,125,992 4,851,333
STOCKHOLDERS' EQUITY: Preferred stock - $.04 par value, 500,000
shares authorized, no shares issued or outstanding -- -- Common
stock - $.04 par value, 15,000,000 shares authorized, 12,398,131
and 11,925,086 shares issued, and 12,291,454 and 11,812,493
outstanding, respectively 495,925 477,003 Additional paid-in
capital 26,156,864 24,775,995 Common stock held in treasury
(106,677 and 112,593 shares, respectively) (375,813) (386,834)
Retained earnings (accumulated deficit) (10,436,794) (10,648,912)
Cumulative translation adjustment 12,904 (8,112) ------------
------------ Total stockholders' equity 15,853,086 14,209,140
------------ ------------ TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY $22,979,078 $19,060,473 ============ ============ *T
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024